Lotrel (PD-Rx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Lotrel drug offered from PD-Rx Pharmaceuticals, Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PD-Rx Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | amlodipine besylate and benazepril hydrochloride |
SUBSTANCE NAME: | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1995-03-03 |
END MARKETING DATE: | 0000-00-00 |
Lotrel HUMAN PRESCRIPTION DRUG Details:
Item Description | Lotrel from PD-Rx Pharmaceuticals, Inc. |
LABELER NAME: | PD-Rx Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 10(mg/1; mg/1) |
START MARKETING DATE: | 1995-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55289-096_5abd2a9a-9eae-3f0c-e053-2a91aa0a9ebe |
PRODUCT NDC: | 55289-096 |
APPLICATION NUMBER: | NDA020364 |
Other AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: